Mineralocorticoid receptor antagonists in the treatment of patients with heart failure after myocardial infarction and those with chronic heart failure

Mineralocorticoid receptor antagonists in the treatment of patients with heart failure after myocardial infarction and those with chronic heart failure

The mineralocorticoid receptor antagonists spironolactone and eplerenone have become part of standard medical therapy for heart failure (HF). Randomized clinical trials have shown the clinical efficacy of spironolactone and eplerenone, which lead to lower death rates in patients with systolic HF. Wh...

Full description

Bibliographic Details
Main Authors: S N Tereshchenko, I V Zhirov, Iu F Osmolovskaia
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2013-12-01
Series:Терапевтический архив
Subjects:
aldosterone
mineralocorticoid receptor antagonists
chronic heart failure
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31414

Similar Items

Similar Items